These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2512699)

  • 1. Increase of major histocompatibility complex class II--positive cells in cardiac allografts by interferon-gamma has no impact on graft survival.
    Ijzermans JN; Bouwman E; van der Meide PH; Jeekel J; Marquet RL
    Transplantation; 1989 Dec; 48(6):1039-41. PubMed ID: 2512699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets.
    Stegall MD; Tezuka K; Oluwole SF; Engelstad K; Jing MX; Andrew J; Hardy MA
    Transplantation; 1990 Feb; 49(2):246-51. PubMed ID: 2137652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression.
    Saito S; Foegh ML; Motomura N; Lou H; Kent K; Ramwell PW
    Transplantation; 1998 Dec; 66(11):1424-31. PubMed ID: 9869082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.
    Forbes RD; Parfrey NA; Gomersall M; Darden AG; Guttmann RD
    J Exp Med; 1986 Oct; 164(4):1239-58. PubMed ID: 3531383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells.
    Ferry B; Halttunen J; Leszczynski D; Schellekens H; vd Meide PH; Häyry P
    Transplantation; 1987 Oct; 44(4):499-503. PubMed ID: 3118519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
    Wood KJ; Hopley A; Dallman MJ; Morris PJ
    Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.
    Pêche H; van Denderen B; Roussel JC; Trinité B; Soulillou JP; Cuturi MC
    Transplantation; 2004 Mar; 77(5):733-40. PubMed ID: 15021837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts.
    Klempnauer J; Steiniger B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182
    [No Abstract]   [Full Text] [Related]  

  • 19. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells.
    Okuda T; Ishikawa T; Azhipa O; Ichikawa N; Demetris AJ; Starzl TE; Murase N
    Transplantation; 2002 Jul; 74(1):103-11. PubMed ID: 12134107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.